CLDX - Celldex Therapeutics, Inc Opinions

Jun 07 at 4:00PM (EST) (By StocksHaven)

Top 85%

Clinical FDA Updates: ANTH, CBLI, CLDX, BMY

FDA Updates: Anthera Pharmaceuticals (NASDAQ:ANTH), Cleveland BioLanbs (NASDAQ:CBLI), Celldex Therapeutics (NASDAQ:CLDX), Bristol Myers (NYSE:BMY) ANTH: A-002 (varespladib methyl) once daily, oral inhibitor of sPLA2 enzyme, Clinicaltrials.gov IDNCT011302...

0 Comments Symbols: ACS, A, BMY, CBLI, ANTH, CLDX

Jan 14 at 11:49AM (EST) (By VicthebrickV)

Top 1%

PARD Starting to move before announced conference at end of January

PARD's corporate announcement last week discussed a another conference call about further drug testing results (their lung cancer drug) at the end of January. Since there is a huge short interest in the stock right now, we may see more short covering f...

25 Comments Symbols: PARD, ARYX, CRIS, IMMU, TIA, MG, HI, CRC, CLDX, RDEA, OREX

Dec 21 2009 at 5:30PM (EST) (By MikeHavRx)

Top 1%

Mentor Capital Plans Early ’10 Launch of Cancer Vaccine Active Index Fund

Last week, Mentor Capital (OTC: MNTR.PK) announced plans to launch an actively managed Cancer Immunotherapy (CI) Index fund shortly after New Year’s Day that will be based on the underlying Mentor Capital CI Index, which has gained 45% on an equal-weight ...

0 Comments Symbols: IP, DNDN, CI, CLDX, C

Nov 28 2009 at 11:34AM (EST) (By MikeHavRx)

Top 1%

Cancer Vaccines: Investing Opportunities beyond Dendreon (NASDAQ: DNDN)

Despite the setbacks and pitfalls experienced by early-stage pioneers in the cancer immunotherapy / therapeutic cancer vaccine space such as Cell Genesys, Favrille, and Genitope; recent advancements and study results are encouraging while Dendreon (NASDAQ...

0 Comments Symbols: III, MNKD, AGEN, PFS, ONTY, GBM, CVM, ACI, CLDX, T, CRL, NCI, INO, IV, PSA, DNDN, PFE, CI, PMA, IND, NIH

Oct 27 2009 at 9:17AM (EST) (By MikeHavRx)

Top 1%

ImmunoCellular (OTC: IMUC.OB): Impressive P1 Survival Data for Brain Cancer Vaccine

As a follow up to my article on FDA Calendar stocks for October, ImmunoCellular Therapeutics (OTC: IMUC.OB) presented additional data at the Congress of Neurological Surgeons Annual Meeting in New Orleans which demonstrated that the Company’s cancer stem ...

0 Comments Symbols: ET, DC, AGEN, PFS, EXEL, GBM, IND, CLDX, TAA, SWX

Oct 19 2009 at 8:39PM (EST) (By MikeHavRx)

Top 1%

Celldex Therapeutics (NASDAQ: CLDX): Plenty of Cash and Pending Clinical Catalysts

At the beginning of the month, Celldex Therapeutics (NASDAQ: CLDX) announced the successful completion of its acquisition of CuraGen (formerly CRGN), which strengthens the balance sheet (approx. $85 million in cash / equivalents) while expanding the pipel...

0 Comments Symbols: CRGN, III, NMB, IP, GBM, BMY, CLDX, MR, GSK, PRF, E, PFE, NY, IND, TAA

Sep 06 2009 at 5:53PM (EST) (By MikeHavRx)

Top 1%

Small-Cap Stocks Battling Brain Cancer

Each year nearly 20,000 people in the U.S. are diagnosed with primary brain cancers (with a similar number in Europe), according to NCI/NIH statistics, with Schering-Plough's (NYSE:SGP) Temodar (temozolomide or TMZ is classified as a DNA-methylating chemo...

0 Comments Symbols: GCV, TK, CRIS, TMZ, DC, SNY, GBM, YMI, CHMP, BMY, CLDX, MET, T, NCI, SGP, IV, PPHM, MHC, EXEL, CSC, PFE, MAA, IND

Sep 01 2009 at 6:00PM (EST) (By MikeHavRx)

Top 1%

ImmunoCellular: Leading Developer for a New Paradigm in Cancer Treatment

ImmunoCellular Therapeutics (IMUC.OB) is an emerging cancer immunotherapy company that is developing therapeutic and diagnostic product candidates taking aim at the root cause of the disease, cancer stem cells (CSCs), based on two distinct technology plat...

0 Comments Symbols: CEO, AGEN, ONTY, CSC, DNDN, CI, CVM, GNBT, CLDX, T

Aug 26 2009 at 9:49AM (EST) (By MikeHavRx)

Top 1%

ImmunoCellular (IMUC.OB): Taking Aim at the Root of Cancer

ImmunoCellular Therapeutics (IMUC.OB) is an emerging cancer immunotherapy company that is developing therapeutic and diagnostic product candidates taking aim at the root cause of the disease, cancer stem cells (CSCs), based on two distinct technology plat...

0 Comments Symbols: IP, AGEN, PFS, ONTY, GBM, CVM, GNBT, CLDX, T, CEO, DNDN, CSC, CI, IND, M

Aug 26 2009 at 8:59AM (EST) (By MikeHavRx)

Top 1%

Mentor Capital (MNTR.PK): A Stealth Cancer Immunotherapy Play

On 7/8/09, in the first of four steps leading to an anticipated merger and name change, Mentor Capital (MNTR.PK) acquired a 20% ownership stake in an innovative clinical stage cancer immunotherapy company, Quantum Immunologics, Inc. (QI). QI is a privatel...

0 Comments Symbols: AGEN, ONTY, BMR, CVM, GNBT, ACI, B, CLDX, T, CEO, NCI, CB, Q, DNDN, CI

Opinions on Celldex Therapeutics, Inc (NASDAQ:CLDX)